Feedback / Questions
Elfabrio (pegunigalsidase alfa-iwxj) - Protalix, Chiesi
Kwangdong secures approval for Fabry disease treatment Elfabrio
(Korea Biomedical Review)
May 22, 2026
Korea approval
•
Fabry Disease
https://www.koreabiomed.com/news/articleView.html?idxno=31771
May 22, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next